ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years
Yiqun Fan
Matched on ORCID iD 0000-0002-1883-0649; OpenAlex author ID A5047980612. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 7
- Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41746-025-02303-9↗
- Microbiota in pancreatic cancer: Roles in tumor initiation and progression (Review). First author DOI 10.3892/ol.2026.15746↗
- Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study. Co-author DOI 10.1007/s11096-025-01866-7↗
- Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort… Co-author DOI 10.1002/cam4.70388↗
- Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography. Co-author DOI 10.1016/j.eclinm.2021.101215↗
- Multi-institutional development and external validation of machine learning-based models to predict relapse risk of pancreatic ductal adenocarcinoma after radi… Co-author DOI 10.1186/s12967-021-02955-7↗
- Exosomes Derived from Pancreatic Cancer Cells Induce Osteoclast Differentiation Through the miR125a-5p/TNFRSF1B Pathway. Co-author DOI 10.2147/ott.s282319↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yulian Wu · 5 shared papers, 2021–2026 · strength 0.83
- Paper Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic duc… DOI 10.1038/s41746-025-02303-9↗
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Paper Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagn… DOI 10.1016/j.eclinm.2021.101215↗
- Hongxia Xu · 3 shared papers, 2024–2026 · strength 0.72
- Paper Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study. DOI 10.1007/s11096-025-01866-7↗
- Paper Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic duc… DOI 10.1038/s41746-025-02303-9↗
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Yanjun Lou · 1 shared paper, 2026 · strength 0.63
- Xiawei Li · 3 shared papers, 2021–2024 · strength 0.46
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Paper Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagn… DOI 10.1016/j.eclinm.2021.101215↗
- Paper Multi-institutional development and external validation of machine learning-based models to predict relapse risk of pan… DOI 10.1186/s12967-021-02955-7↗
- Yuxuan Zhan · 1 shared paper, 2025 · strength 0.30
- Xiawei Li · 1 shared paper, 2026 · strength 0.24
- Yongji Sun · 1 shared paper, 2024 · strength 0.18
- Tianye Niu · 1 shared paper, 2022 · strength 0.15
- Yi Zhu · 1 shared paper, 2021 · strength 0.13
- Yizhao Zhou · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.